Related Experiment Video
Updated: Apr 17, 2026
13:04
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
24.9K
Interferon alpha (IFNα)-induced TRIM22 interrupts HCV replication by ubiquitinating NS5A
Chen Yang1, Xinhao Zhao2, Dakang Sun3
1State Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
Cellular & Molecular Immunology
|February 17, 2015
Summary
Interferon alpha (IFNα) treatment upregulates TRIM22, a protein that targets hepatitis C virus (HCV) NS5A. This TRIM22 upregulation helps reduce viral load in HCV patients and inhibits viral replication in cell cultures.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Hepatitis C virus (HCV) infection is a significant global health concern.
- Interferon alpha (IFNα) therapy is used for HCV treatment, but its efficacy can be limited.
- The role of tripartite-motif (TRIM) protein 22 (TRIM22) upregulation during IFNα treatment for HCV remains unclear.
Purpose of the Study:
- To investigate the antiviral function of TRIM22 in hepatitis C virus (HCV) infection.
- To elucidate the mechanism by which TRIM22 affects HCV replication and IFNα therapy resistance.
- To determine the relationship between TRIM22 upregulation and HCV viral load decline during IFNα treatment.
Main Methods:
- Correlative analysis of TRIM22 levels and viral titer in peripheral blood mononuclear cells (PBMCs) from HCV patients undergoing IFNα treatment.
- In vitro studies using the Huh-7 hepatocyte cell line to assess the effect of TRIM22 on HCV replication.
- Overexpression and Small interfering RNA (siRNA)-mediated knockdown of TRIM22.
- Assessment of TRIM22's ubiquitination of the HCV NS5A protein.
Main Results:
- TRIM22 upregulation in HCV patients' PBMCs correlated with decreased viral titer within 24 hours of initiating IFNα treatment.
- TRIM22 overexpression inhibited HCV replication in Huh-7 cells.
- TRIM22 knockdown diminished the anti-HCV effects of IFNα.
- TRIM22 was found to ubiquitinate the HCV NS5A protein in a concentration-dependent manner.
Conclusions:
- TRIM22 upregulation is associated with reduced HCV viral load during IFNα treatment.
- TRIM22 plays a significant role in controlling HCV replication, likely through targeting the NS5A protein.
- TRIM22 represents a potential therapeutic target for enhancing IFNα-based HCV treatment.
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
37
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
37
01:25Hepatitis
63
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
63
01:29Viruses with RNA Genomes
1.4K
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
1.4K
01:29Immune Response Against Viral Pathogens
2.7K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.7K
02:30siRNA - Small Interfering RNAs
19.1K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
19.1K
01:52Eukaryotic Transcription Inhibitors
11.7K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.7K